Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 12525732.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Gene mutations within the P/Q type neuronal calcium channel in familial hemiplegic migraine (FHM) suggest a therapeutic role for calcium-channel blockade. The authors have previously reported abortive therapy of FHM with IV verapamil. Here the authors describe four cases of sporadic hemiplegic migraine (SHM) responsive to verapamil, administered either orally or IV. The findings indicate that verapamil is effective therapy for both SHM and FHM.
Medical subject headings
- Calcium Channel Blockers
- Hemiplegia
- Migraine with Aura
- Verapamil